IFNA17 and hepatocellular carcinoma: Some studies, however, found that IFN-α could provide a significant benefit in both OS and RFS for HCC patients undergoing curative surgery, and that IFN-α therapeutic response could be predicted by hepatic retinoic acid-inducible gene-I and tetratricopeptide repeats 3 [209–211].